U.S. Banks Stock News

NasdaqGS:WSBC
NasdaqGS:WSBCBanks

Is It Too Late To Consider WesBanco (WSBC) After A 34% One Year Rally?

If you are asking whether WesBanco at US$36.36 still offers value or if most of the opportunity is already reflected in the price, you are in the right place. The stock has returned 0.8% over the last 7 days, 9.8% over the last 30 days, 9.1% year to date and 34.5% over the past year. Returns of 46.1% over 3 years and 20.8% over 5 years provide additional context. These returns have drawn more attention to how the market currently prices WesBanco and what is built into expectations. In the...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

Is GE HealthCare Technologies (GEHC) Attractive After 9.9% Year-To-Date Share Price Decline?

If you are wondering whether GE HealthCare Technologies is attractively priced or starting to look stretched, the current setup offers plenty for valuation focused investors to unpack. The stock last closed at US$74.66, with returns of 2.0% over 7 days, 7.2% over 30 days, a 9.9% decline year to date, and a 20.0% gain over 1 year, which gives a mixed picture of recent performance. Recent coverage has centered on GE HealthCare Technologies as a standalone medical technology player following...
NYSE:PHM
NYSE:PHMConsumer Durables

Is It Too Late To Reassess PulteGroup (PHM) After Strong Multi‑Year Share Price Gains?

If you are wondering whether PulteGroup's current share price lines up with its fundamentals, or if the market is getting ahead of itself, this article will walk you through what the numbers say about value. The stock last closed at US$126.53, with returns of 5.2% over 7 days, 10.5% over 30 days, 6.3% year to date, 34.3% over 1 year, 106.1% over 3 years and 146.3% over 5 years, which naturally raises questions about how much optimism is already priced in. Recent headlines around PulteGroup...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

Netflix (NFLX) Is Down 5.5% After Reed Hastings’ Exit News And Soft Q2 Outlook - What's Changed

In April 2026, Netflix reported first-quarter results that beat expectations but issued softer-than-anticipated guidance for second-quarter revenue of about US$12.57 billion and earnings of US$0.78 per share while confirming its full-year 2026 outlook. The company also revealed that co-founder and chair Reed Hastings will leave the board in June, raising fresh questions about leadership continuity just as Netflix leans more on advertising, price increases and new products such as its ad-free...
NYSE:VOYG
NYSE:VOYGAerospace & Defense

A Look At Voyager Technologies (VOYG) Valuation After Recent Share Price Pullback

Voyager Technologies stock snapshot after recent trading move Voyager Technologies (VOYG) has caught attention after a 3.8% decline in the latest session, trimming recent gains that saw the stock rise about 23% over the past month and 13% year to date. See our latest analysis for Voyager Technologies. While the latest 1 day share price return of a 3.78% decline to $31.31 has cooled sentiment, the 30 day share price return of 22.69% alongside a weaker 90 day share price return of 11.5%...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Warner Bros. Discovery Insider Sales And Merger Risks Weigh On Outlook

Warner Bros. Discovery executives have recently reported significant insider share sales as debate around a major studio merger intensifies. Prominent directors and writers are publicly opposing the proposed consolidation, raising concerns about creative control and bargaining power. The United Kingdom's Competition and Markets Authority has opened a formal inquiry into the merger's potential international effects. For investors tracking NasdaqGS:WBD, these developments sit alongside a...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

A Look At Luckin Coffee (OTCPK:LKNC.Y) Valuation After Recent Share Price Moves

Event context and recent share performance Luckin Coffee (OTCPK:LKNC.Y) has drawn investor attention after recent trading, with the stock last closing at $33.79 and showing a 3.5% one day move, alongside mixed returns over the month and past 3 months. See our latest analysis for Luckin Coffee. While the latest 3.5% one-day share price return has caught attention, the year-to-date share price return of a 4.6% decline contrasts with a 10.6% one-year total shareholder return and a very large...
NYSE:KNSL
NYSE:KNSLInsurance

Is It Time To Reconsider Kinsale Capital Group (KNSL) After Recent Share Price Rebound?

Wondering if Kinsale Capital Group at US$360.78 is a bargain, a premium, or somewhere in between? This article walks through the numbers so you can judge the current price with more confidence. The stock has returned 3.6% over the last 7 days and 9.9% over the last 30 days, yet it is still down 8.1% year to date and 25.6% over the past year, following a 108.1% return over 5 years. Recent share price moves have kept Kinsale Capital Group on many investors' watchlists, as they weigh up how the...
NasdaqGS:SIGI
NasdaqGS:SIGIInsurance

Lagging EPS And ROE Versus Peers Might Change The Case For Investing In Selective (SIGI)

Recently, a critical article highlighted that Selective Insurance Group’s earnings per share and book value growth have trailed peers, raising questions about management’s capital allocation and return on equity compared with other insurers. This negative analyst commentary has drawn attention to the gap between Selective’s current performance metrics and those of its industry rivals, putting management’s execution under closer investor scrutiny. Now we’ll examine how concerns over lagging...
NYSE:EPAM
NYSE:EPAMIT

Does EPAM Systems’ (EPAM) Special-Meeting Debate Reveal a Deeper Shift in Governance Power?

EPAM Systems, Inc. previously proposed amending its Fourth Amended and Restated Certificate of Incorporation to allow shareholders to call special meetings, alongside urging investors in its April 6, 2026 definitive proxy filing to vote against a separate shareholder proposal seeking a 10% ownership threshold for calling such meetings. This contrast between management’s preferred approach and an activist-backed, lower threshold highlights an evolving power balance over how quickly investors...
NYSE:ONTO
NYSE:ONTOSemiconductor

Is It Too Late To Consider Onto Innovation (ONTO) After A 152.9% One Year Rally?

Wondering whether Onto Innovation at around US$290.76 is offering good value or stretched pricing? This article breaks down what the current market is implying about the stock. The share price context includes a 13.1% return over the last 7 days, 45.3% over 30 days, 75.3% year to date, 152.9% over 1 year, 251.5% over 3 years and 315.5% over 5 years. These moves sit against a backdrop where investors are paying closer attention to semiconductor suppliers tied to advanced manufacturing and...
NasdaqGS:WWD
NasdaqGS:WWDAerospace & Defense

Is It Too Late To Consider Woodward (WWD) After Its 134% One-Year Surge?

For readers wondering whether Woodward's recent share price puts it at a bargain or a stretch, this article walks through the numbers so you can judge how the current price lines up with underlying value. The stock last closed at US$394.83, with returns of 1.6% over 7 days, 11.7% over 30 days, 27.0% year to date, 134.4% over 1 year, 327.0% over 3 years and 228.0% over 5 years. These moves have kept Woodward on many investors' radar, with recent coverage focusing on what might be driving such...
NYSE:EVR
NYSE:EVRCapital Markets

Evercore Private Markets Forum Highlights Push Into Broader Advisory Fee Pools

Evercore (NYSE:EVR) plans to host its third annual Private Markets Forum in New York. The event will bring together senior leaders from around 20 private markets asset management firms. Discussions are expected to focus on trends, risks, and opportunities in private capital markets. Evercore, an independent investment banking advisory firm, is using this forum to engage directly with major private markets managers at a time when private capital continues to play a central role in global...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

Will Renewed Institutional Buying After Share Weakness Shift MercadoLibre’s (MELI) Fintech-Led Growth Narrative?

In the first quarter, Fisher Funds Management and Sara-Bay Financial increased their positions in MercadoLibre, together adding nearly 37,000 shares worth over US$71 million, following earlier share price weakness but in the context of strong recent revenue growth and fintech expansion. This renewed interest from institutional investors underlines confidence in MercadoLibre’s efforts such as lowering free shipping thresholds in Brazil to attract more buyers, boost purchase frequency, and...
NYSE:RTX
NYSE:RTXAerospace & Defense

Is It Too Late To Consider Buying RTX (RTX) After Its 55% One-Year Rally?

If you are wondering whether RTX is still reasonably priced after its recent run, it helps to step back and look at what the current share price might already be assuming. The stock closed at US$196.42, with returns of 4.9% year to date and 55.0% over the last year, following a 2.6% pullback in the past week and a 0.9% move over the last month. Recent headlines around RTX have focused on its position within the Aerospace and Defense sector and its role as a large US contractor. This keeps...
NYSE:FBK
NYSE:FBKBanks

Assessing FB Financial (FBK) Valuation After Q1 Earnings Growth And Share Buybacks

Earnings, buybacks and credit quality in focus FB Financial (FBK) just reported first quarter 2026 results, with higher net interest income and net income than a year ago, alongside an update on share repurchases and credit costs. See our latest analysis for FB Financial. The latest results, share repurchases and relatively contained credit costs come against a backdrop of a 6.05% 1 month share price return and a 34.99% 1 year total shareholder return. This suggests momentum has been uneven...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna (MRNA) Is Up 5.4% After Fast Track Win For Melanoma mRNA Therapy Combo – Has The Bull Case Changed?

Moderna recently presented positive Phase 1/2 data for its investigational cancer antigen therapy mRNA-4359 in combination with pembrolizumab in advanced melanoma, and the U.S. FDA granted the regimen Fast Track designation for a specific PD-L1 positive melanoma population. The strong early response and disease control rates, together with regulatory acceleration, highlight how Moderna is extending its mRNA platform beyond infectious disease vaccines into oncology. We’ll now examine how the...
NYSE:ELF
NYSE:ELFPersonal Products

A Look At E.l.f. Beauty’s Valuation As New Tech And Brand Leaders Take Charge

Executive reshuffle puts technology and brand expansion in focus E.l.f. Beauty (ELF) has shaken up its leadership team, promoting longtime chief marketing officer Kory Marchisotto to president of E.l.f. Brands, naming Oshiya Savur as chief marketing officer, and creating a chief technology and AI officer role for Ekta Chopra. The company is explicitly positioning technology and artificial intelligence as central to its growth plans, a development that could influence how you think about the...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Is It Too Late To Consider Amgen (AMGN) After A 32% One-Year Share Price Rally?

If you are wondering whether Amgen’s share price still offers value after a strong run, this breakdown will help you weigh what you are really paying for. At a last close of US$355.30, the stock has returned 1.2% over 7 days, 2.2% over 30 days, 8.4% year to date, 32.2% over 1 year, 60.1% over 3 years, and 61.7% over 5 years. These figures raise fair questions about what is already reflected in the price. Recent attention around Amgen has focused on its role as a large US biotech, with...
NYSE:GNRC
NYSE:GNRCElectrical

A Look At Generac Holdings (GNRC) Valuation After New CPower Distributed Generation Partnership

Generac Holdings (GNRC) recently announced a collaboration with CPower Energy to deploy distributed generation across the PJM market, focusing on battery storage, generators and microgrids for commercial and industrial customers. See our latest analysis for Generac Holdings. The latest partnership news comes as Generac’s share price, now at $212.10, has seen a 6.42% 1 month share price return and a 31.86% 3 month share price return, with 1 year total shareholder return of 89.85% pointing to...
NYSE:WH
NYSE:WHHospitality

How Investors May Respond To Wyndham Hotels & Resorts (WH) Adding Wells Fargo Points Transfers To Rewards Program

Earlier this month, Wells Fargo announced that Wyndham Rewards joined its Rewards Points Transfer program, allowing eligible Wells Fargo credit cardholders to convert points into Wyndham stays at a 1:2 ratio across thousands of properties worldwide. This move deepens Wyndham’s reach into bank-led loyalty ecosystems, potentially increasing customer engagement with its rewards program and enhancing the appeal of its largely midscale and economy hotel portfolio. We’ll now explore how the Wells...
NYSE:NOW
NYSE:NOWSoftware

A Look At ServiceNow (NOW) Valuation After Broad AI Platform Rollout And New Partnerships

ServiceNow (NOW) has been in focus after announcing that every product in its portfolio now ships with built-in AI, data connectivity, workflow execution, security, and governance, along with fresh integrations and ecosystem partnerships. See our latest analysis for ServiceNow. Despite a series of AI focused product launches and partnerships in April, ServiceNow’s 7 day share price return of 16.5% comes after a year to date share price decline of 34.5% and a 1 year total shareholder return...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Astronics Qi2 Wireless Charging Launch Tests Cabin Power Growth Story

Astronics (NasdaqGS:ATRO) has introduced its new EmPower Qi2 Wireless Charging Module for aircraft cabins, galleys, and crew rest areas. The module supports the latest Qi enabled and MagSafe compatible devices and is designed for rapid maintenance and compliance with aviation standards. Astronics focuses on aerospace and defense electronics, with cabin power and connectivity as a core part of its business. The EmPower Qi2 Wireless Charging Module fits directly into that franchise and aims...
NasdaqGS:AKTS
NasdaqGS:AKTSBiotechs

Aktis Oncology Board Shift And New Committee Draw Investor Focus On R&D

Aktis Oncology (NasdaqGS: AKTS) has appointed Dr. Glenn Gormley as an independent director to its Board. Dr. Gormley will also serve as co-chair of a newly formed Science and Technology Committee. The company announced upcoming departures of two current Board members as part of this transition. Aktis Oncology, trading on NasdaqGS under the ticker AKTS, recently closed at $20.25. The stock is up 20.0% over the past week and 14.4% over the past 30 days, while the year-to-date return stands at...